Oracle's 664 Billion Reasons to Grow, and One Shrinking Number That Worries Analysts

Oracle's revenue rose 30% and backlog hit $664 billion, yet the stock slipped 1.4% as gross margin fell to 61% and restructuring costs grew.

Oracle delivered a quarter that, on paper, ought to have set off fireworks: revenue up 30%, a backlog of 664 billion dollars, and a raised full-year outlook. Instead, the stock has slipped 1.4% since the numbers landed. That gap between headline and market reaction is the real story here — not the figures themselves, but why investors refused to cheer them.

Growth at a price

The cloud infrastructure unit, IaaS, surged 121% to 7.4 billion dollars, while total cloud revenue climbed 62% to 11.6 billion dollars. Those are eye-catching numbers by any measure. Yet in the very same report, gross margin contracted from 66.3% in the prior quarter to 61%.

When a company scales AI data-center capacity as aggressively as Oracle is, it appears to be buying growth with declining profitability. That is not a catastrophe, but it is a warning worth heeding before getting swept up by the "record backlog" headline. Adding to the pressure, Oracle confirmed it had to top up restructuring costs by another 700 million dollars, bringing the full program for fiscal 2026 to roughly 2.8 billion dollars.

A business that is simultaneously booking billions in orders and cutting staff sends a mixed message. It suggests management itself is not entirely convinced the current spending pace pays off without offsetting moves elsewhere.

The backlog is real — but it is also a promise

More than 30 billion dollars in additional AI cloud contracts were booked during the quarter, lifting total remaining performance obligations by 209 billion dollars year over year to 664 billion dollars. That is an impressive expression of demand. But a backlog is not cash flow.

Between signing a contract and actually recognizing revenue, data-center projects stretch across years, and the margin at which those orders ultimately settle is not yet fixed. It is striking how much of the public debate around Oracle fixates on this single figure, while the margin trajectory in the same report draws far less attention.

The dividend of 0.50 dollars per share, payable on October 23 to shareholders of record as of October 9, does little to change that assessment. It signals continuity, not operational strength.

Analysts split sharply on what comes next

The mixed signals sent research desks in opposite directions. Barclays raised its price target to 252 dollars from 250 dollars, arguing Oracle's growth had "inflected." UBS followed, lifting its target to 250 dollars from 245 dollars. On the other side, BMO Capital cut its target to 195 dollars from 220 dollars while keeping a buy rating. Stifel trimmed to 200 dollars from 220 dollars, and RBC Capital made the deepest reduction, dropping to 165 dollars from 190 dollars with a neutral rating. D.A. Davidson initiated coverage with a buy rating and a 180-dollar target.

The wide spread — from 165 to 252 dollars — captures the fundamental uncertainty over how heavily the massive cloud investments will weigh on profitability in the coming quarters. Investors will likely focus on free cash flow development when the next set of results arrives, scheduled for December 14.

The spending bill behind the growth

Oracle reaffirmed its full-year capital expenditure guidance of 90 to 95 billion dollars, though net cash investments, after accounting for customer prepayments and financing arrangements, should not exceed 70 billion dollars. For the full fiscal year 2027, revenue is projected to reach at least 90 billion dollars, equivalent to 34% growth in constant currency. For the current second quarter, the company guided to revenue growth of 30% to 34% and cloud growth of 64% to 71%.

Operationally, GPU capacity utilization stood at 97.9%, and 850 megawatts of new data-center capacity came online during the reporting period. Those are the kind of metrics that underpin the bullish case — and the reason the more skeptical analysts zero in on the same spending that makes them possible.

A regulatory sideshow, for now

Roughly two weeks ago, it emerged that the European Commission is examining Oracle's software licensing practices. Since then, the stock has actually gained 3.1%, suggesting the market currently assigns little weight to the matter. Reuters stressed it is a preliminary information-gathering exercise, not a formal proceeding. It is a side stage — worth watching, but not the driver of the recent weakness.

The chart tells its own story

Trading data reinforces the cautious read. At a closing price of 129.72 euros, Oracle sits about 54% below its 52-week high of 279.35 euros, reached last September. Year to date, the stock is down 22%. On a weekly basis, it has lost 5.1%, and it now trades 55% below the 288.95-euro peak touched last September.

This is not the picture of a stock carried by AI euphoria. It is the picture of a revaluation, in which investors weigh the heavy investment costs more heavily than the growth rates.

The bottom line

Oracle is delivering genuinely impressive operational growth. But the combination of shrinking margins, rising restructuring costs, and a backlog that has yet to be converted into cash tempers the narrative of an unstoppable AI winner. The odds that the business pays off over the long run remain real — yet for now, the risk that the market focuses on the operational drag rather than the growth figures appears to dominate. Anyone betting on Oracle should recognize they are wagering on a future margin recovery rather than buying confirmation of present strength.